Company intelligence / Profile preview

Biologics by McKesson

Cary, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Biologics by McKesson provides specialty pharmacy dispensing, access solutions, and patient support services for FDA-approved oncology and rare disease therapies. It is often selected by major drug manufacturers for exclusive or limited distribution—recent launches include PIQRAY® (alpelisib) and VIJOICE® (alpelisib).

Therapeutic areas: OncologyRare Diseases
Modalities: monoclonal antibodysmall molecule
Industry: Non-Academic Healthcare

Partnerships

Major partnerships with pharmaceutical firms for specialty drug distribution (e.g., exclusivity with PIQRAY®, VIJOICE®)

Beyond the preview

Go deeper on Biologics by McKesson.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biologics by McKesson.

Explore the full profile